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ABSTRACT
Surgical-site infection (SSI) is the most prevalent type of hospital infection in surgical patients and is as-
sociated with an increase in hospital stay, costs and morbidity/lethality. The knowledge of the main risk 
factors for this type of infection is important for the establishment of prevention measures regarding mod-
ifiable risks factors. The objective of the preset study was to assess the occurrence of SSI and study the risk 
factors in oncologic surgeries of the digestive system at Hospital de Câncer in Barretos, São Paulo, Brazil. 
Individuals undergoing oncologic surgeries of the digestive system in the period of 08/01/2007 to 
08/10/2008 were prospectively followed for 30 days after surgery. Possible risk factors related to the 
patient and to the surgical procedure were also studied. A total of 210 surgeries were analyzed, with 
a global SSI incidence of 23.8%. The following variables were independently associated with SSI: time 
and type of surgery, radiotherapy before surgery and surgeon’s years of experience. The risk factors 
found in this study have been described by other authors and are not amenable to intervention for 
SSI prevention. Further studies are recommended with the objective of investigating interventions 
that could reduce the risk for SSI in this type of surgery. 
Keywords: infection; surgical site; oncologic surgery; digestive system surgery. 
[Braz J Infect Dis 2011;15(2):109-115]©Elsevier Editora Ltda.
INTRODUCTION
Midway through the twentieth century, it 
was believed that pain, anesthetic incidents, 
surgical wound infection and postoperative 
sepsis, which were important obstacles to 
the success of surgical treatment, had been 
overcome. In a way, such predictions came to 
pass; however, these complications are still 
around and persist as causes of postoperative 
morbidity and lethality.1-3 
It is estimated that 500,000 cases of surgi-
cal-site infection (SSI) occur annually in the 
United States of America (USA) and, among 
the ranking of hospital infections, SSI is 
among the most frequent ones, contribut-
ing with 14% to 16% of the cases.1,3 However, 
among surgical patients, SSI is the hospital in-
fection with the highest incidence, represent-
ing 38% of all infections in this population.1,4
SSI has a great impact on mortality, as 30% 
to 40% of the deaths in the postoperative pe-
riod are caused by this infection.5 When pa-
tients with SSI die, the SSI itself is the cause of 
death, most cases (93%) with severe infections 
involving organs and spaces.1 Another impor-
tant consequence, with considerable impact 
for the healthcare system and society, is the 
impact on healthcare costs.1,5-7 In the USA, it 
is estimated that the annual excess costs due 
to SSI is > 1.6 billion dollars.6 Among the fac-
tors that contribute the most to the cost in-
crease is the length of hospital stay, with a de-
scribed mean increase of 5.7 to 13.7 days.5,7-10 
The need to prescribe antibiotics and perform 
reoperations as well as laboratory and radio-
logic assessments also has a considerable im-
pact on healthcare expenditures.3,8 
SSI is a multifactorial condition and the risk 
factors involved in its onset are common for 
most surgeries (age, obesity, surgical time, etc); 
however, other factors are peculiar to certain 
procedures. Thus, it is important to identify 
these factors to evaluate the procedures that 
carry the highest risk and, if possible, define 
adequate indices that can predict the risk of SSI 
in different types of surgery.11
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Hospital de Câncer in the town of Barretos, São Paulo 
State, Brazil, is specialized in oncology and performs around 
6,000 surgeries annually, with approximately 11% being ne-
oplasias of the digestive tract. In spite of the relevance of SSI, 
this is the first study of systematic collection of information 
on its distribution and characteristics in this hospital.
The study was approved by the Ethics Committee in Re-
search of Hospital de Câncer de Barretos, process # 95/07.
METHODS
Individuals aged 18 years and older, undergoing cura-
tive or palliative surgery for primary malignant neopla-
sias of the digestive system from August 1, 2007 to July 
31, 2008, were enrolled in the study. Those who had not 
completed 30 days of postoperative follow-up were ex-
cluded, except cases of death due to SSI before comple-
tion of the 30-day period.
Information on the following variables were collected 
for each study participant: name, hospital registration 
number, age, sex, level of schooling, cancer type, neoplasia 
staging, diabetes mellitus, nutritional status and obesity, 
history of alcohol consumption, smoking status, surgery 
performed, date of surgery, surgical outcome (curative or 
palliative), surgical condition (elective or emergency), time 
of surgery, radiotherapy on the topography of the operative 
field prior to surgery, chemotherapy prior to surgery, hy-
perglycemia in the perioperative period, polytransfusion 
of blood derivatives in the perioperative period, antibiotic 
prophylaxis (antibiotic agent used, dose, moment of start, 
intraoperative repeat dosing and duration of use), length 
of preoperative hospitalization, surgical team, surgeon’s 
years of experience, ASA classification, type of anesthesia, 
potential for surgery contamination, SSI data (date of di-
agnosis, depth, microbial etiology, evolution). The CDC 
criteria11 were used to diagnose SSI. 
The information were stored in a database and ana-
lyzed using the software SPSS for Windows, release 17.0.
First, the sample was characterized by absolute and 
relative frequencies, central tendency measures (mean 
and median) and dispersion (range and standard de-
viation). For quantitative variables, adherence to the 
normal curve was verified by the Kolmogorov-Smirnov 
test. As the variables did not have a normal distribution, 
the non-parametric Mann-Whitney test was applied to 
compare the groups with and without SSI. Association 
between independent qualitative variables and SSI was 
initially assessed through univariate analysis using the 
Chi-square test or Fisher’s exact test when indicated. 
Subsequently, multiple logistic regression models were 
used to verify the independent association between the 
studied variables and SSI. A p-value ≤ 0.25 was the cut-off 
used to determine which variables would enter the mul-
tivariate model. Statistical significance was set at α = 5%.
RESULTS
Of the 224 potential participants, 14 patients were ex-
cluded: seven did not complete the 30-day follow-up, 
five did not have cancer, and two for reoperation due to 
non-infectious surgical complications before the end of 
the 30-day period. Therefore, the final sample consisted 
of 210 individuals.
Among participants, 59.5% (125/210) were male and 
50% were less than 60 years old. As for the nutritional 
status, 7% (14/210) were malnourished, 48% (97/210) 
were overweight/obese, and 45% (91/210) had normal 
weight. Up to 14.6% (30/205) had diabetes mellitus, 23% 
(48/160) were smokers, and 15.6% (32/205) reported 
history of alcohol consumption. The ASA score was de-
fined in 204 participants and, of these, 30.9% were clas-
sified as ASA 1, 56% as ASA 2 and 12.7% as ASA 3/4. 
Neoplasia staging was assessed in 192 individuals, with 
89 (46.4%) being classified as stages I/II and the remain-
ing as stages III//IV.
Regarding the type of surgery (Table 1), 12.9% 
(27/210) were derivations/jejunum, 23.8% (50/210) were 
of the upper digestive system and 63.3% (133/210) of the 
lower digestive tract. SSI was diagnosed in 50 surgeries 
(23.8%) and most were classified as superficial (46%). 
Deep infections and infections of organs and spaces 
Table 1. Distribution of participants according to the 
characteristics of the surgery and anesthesia, ICU 
stay and development of surgical site infection 
Variables Categories n %
Type of Jejunum/derivation 27 12.9 
surgery Upper digestive 50 23.8 
 Lower digestive 133 63.3
Potential for Potentially contaminated 70 33.3 
contamination Contaminated/infected 140 66.7
Days at ICU** Up to 2 days 18 40.0 
 3 days or more 27 60.0
Type of  General 59 28.4 
anesthesia* Spinal + epidural 25 12.0 
 Spinal + general 124 59.6
Previous  No 111 58.4 
surgery* Yes 79 41.6
Surgical site No 160 76.2 
infection Superficial 23 11.0 
 Deep 10 4.8 
 Organs and spaces 17 8.1
Total  210 100
*Some values are unknown for some participants. 
**Only patients that needed ICU.
Infection risk in oncologic surgery
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represented, respectively, 20% and 34% of the total. 
There was a predominance of contaminated/infected 
surgeries (66.7%), ICU stay ≥ 3 days (60%), absence of 
previous surgery (58.4%), and combination of spinal 
and general anesthesia (59.6%). The mean time between 
surgery and SSI diagnosis was 11.9 days.
Surgical antibiotic prophylaxis was prescribed in 
99.5% of the surgeries and its use was adequate in 74.5% 
of them. The most common inadequacy was the use of 
a lower than recommended dose (10.1%). On the other 
hand, there was a high rate of appropriateness regarding 
the antibiotic agent selected, moment of prophylaxis ini- 
tiation, intraoperative repeat doses and prophylaxis 
period (Table 2).  
As for the etiology of SSI, it was not possible to iden-
tify the agent in 15 patients, as material for laboratory 
analysis was not collected before the start of antibiot-
ics or the surgical procedure for treating the infection. 
Therefore, 70% of the SSI were microbiologically con-
firmed (35/50). Gram-negative bacteria were most fre-
quently isolated, totaling 31 cases with Escherichia coli 
being the most prevalent. Bacteria considered multi-
resistant to antimicrobial agents were isolated from only 
seven cases, mainly oxacillin-resistant Staphylococcus 
aureus. Anaerobic microorganisms were not isolated as 
the Microbiology Laboratory of of Hospital de Câncer de 
Barretos does not have the methodology to isolate these 
pathogens.
Among SSI patients, three died, two due to the un-
derlying neoplasia and one attributed to SSI itself, thus 
resulting in a SSI lethality rate of 2% (1/50).
Statistical analysis of the quantitative variables (Ta-
ble 3) showed that only time of surgery was significantly 
higher among SSI patients, when compared to those 
without SSI (p = 0.007). The logistic regression analysis 
is summarized in Table 4, showing the following varia-
bles that presented a significant independent association 
with SSI: contaminated/infected surgery, lower diges-
tive surgery, adjuvant treatment (chemotherapy and/or 
Table 2. Adequacy of the parameters in the individu-
als that received antibiotic prophylaxis
Variables Categories n %
Use of prophylactic  Yes 209 99,5 
antibiotic agents No 1 0,5
Choice of Adequate 206 99,0 
antibiotic agent Inadequate 2 1,0
Start of Before surgery 187 92,6 
antibiotic therapy During surgery 15 7,4
Intraoperative Yes 29 13,9 
repeat dosing No 11 5,3 
 Not indicated 168 80,8
Dose Adequate 178 89,9 
 Inadequate 20 10,1
Period of Single dose 64 30,9 
prophylaxis Intra-operative 16 7,7 
 Up to 24 hours 118 57,0 
 24 to 48 hours 1 0,5 
	 ≥	48	hours	 8	 3,9
Prophylactic  not adequate 49 25,5 
antibiotics (all  adequate 143 74,5 
parameters together)   
Total  210 100,0
Table 3. Descriptive statistics of the time of surgery, body mass index (BMI) and age according to the presence of SSI
Variables                 Presence of SSI     Absence of SSI   
 n Mean Median Range n Mean Median Range p* 
  (SD)     (SD) 
Time of 50 205.4 (85.7) 192.5 30-420 160 169.8 (82.1) 160.00 25-420 0.007 
surgery (min)
BMI (kg/m2) 48 25.1 (4.8) 25.2 14.7-40.1 151 25.3 (4.9) 24.8 14.5-42.5 0.867
Age (years) 50 59.1 (12.9) 60.0 33-81  160 59.3 (13.5) 59.0 25-85  0.921
*Mann-Whitney.
radiotherapy before surgery), and surgeon’s less years 
of experience. The analysis of the surgeon’s years of 
experience did not show a correlation with the time 
of surgery (p = 0.45). At the multivariate analysis ad-
justed for the presence of diabetes mellitus (Table 5) 
the variables that had an independent significant asso-
ciation with SSI were: surgeon’s experience < 10 years, 
chemotherapy and/or radiotherapy before surgery and 
surgery duration. 
Type of surgery (contaminated or infected) was at 
the threshold of statistical significance. 
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Table 4. Univariate logistic regression analysis according to the presence of surgical-site infection 
Variables Categories Infection Total p (χ2) ORcrude 95% CI 
  n (%) n (%)   
Potential for Potentially contaminated 7 (10.0) 70 (100) 0.001 1.0  
contamination Contaminated/infected 43 (30.7) 140 (100)  3.99 1.689-9.423
Type of surgery Jejunum/derivation 1 (3.7) 27 (100) 0.001 1.0  
 Upper digestive 6 (12.0) 50 (100)  3.54 0.404-31.108 
 Lower digestive 43 (32.3) 133 (100)  12.42 1.631-94.591
Previous surgery No  31 (27.9) 111 (100) 0.316 1.0  
 Yes 17 (21.5) 79 (100)  0.71 0.359-1.394
Clinical staging I/II 23 (25.8) 89 (100) 0.465 1.0  
 III/IV 22 (21.4) 103 (100)  0.78 0.399-1.521
ASA classification 1 and 2 48 (27.0) 178 (100) 0.048 1.0  
 > 2 2 (7.7) 26 (100)  0.23 0.051-0.991
Adequate antibiotic No 8 (16.3) 49 (100) 0.238 1.0  
prophylaxis Yes 35 (24.5) 143 (100)  1.66 0.711-3.878
Adjuvant treatment No 32 (19.3) 166 (100) 0.003 1.0  
 Yes 18 (40.9) 44 (100)  2.89 1.420-5.921
Time of surgeon’s > 10 13 (14.0) 93 (100) < 0.001 1.0  
experience 5 to 10 31 (30.4) 102 (100)  2.68 1.305-5.532 
 < 5 6 (40.0) 15 (100)  4.10 1.251-13.454
Days in ICU Up to 2 days 2 (11.1) 18 (100) 0.684 1.0  
 3 days or more 5 (18.5) 27 (100)  1.82 0.312-10.586
Table 5. Multivariate logistic regression analysis according to the presence of surgical-site infection
Variables Categories ORadjusted** 95% CI p
Type of surgery Potentially 1.0   
 contaminated    
 Contaminated/infected 2.68 0.998-7.218 0.050
Chemo/radiotherapy Yes 2.54 1.150-5.615 0.021 
before surgery No 1.0  
Time of surgery*  1.005 1.001-1.009 0.026
Time of surgeon’s < 5 4.502 1.269-15.972 0.020 
experience 5 to 10 1.982 0.861-4.563 0.108 
 > 10 1.0  
**Adjusted by diabetes mellitus.
*Treated as continuous variable.
DISCUSSION
The observed incidence of SSI in the present study was 23.8%. 
As the incidence from previous reports in the pertinent litera-
ture has a great deal of variability, the SSI incidence observed 
at our hospital would sometimes be considered higher and 
sometimes lower. However, it must be emphasized that few 
studies included only oncologic surgeries.9,12-19
Smith et al.19 reported an incidence of SSI of 25.6%; how-
ever, they assessed only incision infections (superficial and 
deep) in patients undergoing colorectal resections, either 
oncologic or not. Konishi et al.13 also studied only incision 
infections (superficial and deep) in colon and rectal surger-
ies, having found incidences of 9.4% and 18.0%, respective-
ly (p = 0.003). Velasco et al.18 found an incidence of SSI of 
Infection risk in oncologic surgery
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22.4% in oncologic abdominal surgeries, whereas Oliveira 
et al.14 reported an incidence of 22.1% in gastric surgeries, 
either oncologic or not. Imai et al.12 studied 1,116 oncologic 
open gastric surgeries and found an incidence of 13.8%, 
with time of surgery being verified as the only risk factor. 
Another study by Vilar-Compte et al.16 investigated the SSI 
incidence in oncologic surgeries of seven specialties. Over-
all, the SSI rate was 9.3%, being as high as 14.1% in diges-
tive system surgeries. The main associated risk factors were 
diabetes mellitus, obesity and presence of a drain for more 
than five days.
The findings of the present study confirmed the knowl-
edge that surgeries with higher microbial load in the opera-
tive field is associated with higher risk of SSI,1,8,20 considering 
that surgeries of the lower digestive system (contaminated) 
had an incidence of 32.3%, whereas those of the upper diges-
tive system had 12%. In lower digestive system surgeries, the 
incidence found in Barretos was higher than that observed 
by Smith et al.19 and Konish et al.,13 although it must be re-
called that these authors did not account for organ and space 
infections when they studied oncologic and non-oncologic 
surgeries. The latter study found that the incidence of SSI 
was almost two-fold higher in rectal surgeries (18%) than 
in colon surgeries (9.4%), which emphasizes the importance 
of performing a detailed analysis by procedure, as the risk 
can vary even in situations with similar microbial load in 
the operative field. 
In upper digestive system surgeries, the incidence of SSI 
in the present investigation (12%) was lower than the one 
reported by Oliveira et al.,14 Velasco et al.18 and Imai et al.,12 
albeit higher than that reported by the National Nosocomial 
Infection Surveillance System (NNIS).15 
The comparison of SSI incidence between hospitals from 
different locations and countries must always be carefull, as 
there are specific characteristics for each place and patient 
population that make it difficult to reach valid conclusions. 
The ideal situation would be for each hospital to critically 
analyze its own data, preferably focusing such analysis on 
the historical series and particularizing it for the several 
types of surgery.
In the present study, the variables that had a statistical 
association with SSI (type of surgery, surgeon’s experience, 
duration of surgery and chemo/radiotherapy before the sur-
gery) are risk factors that have been previously reported by 
other authors in different investigations.12,14,17,18,21-23
Of the neoplasms assessed in the present study, chemo-
therapy/radiotherapy before the surgical procedure is only 
indicated for lower rectal tumors. This might be a con-
founding variable, as surgeries with resection of the rectum 
already have an increased risk of infection due to the high 
microbial load present in the operative field, in addition to 
the low anastomosis, close to the anal border, thus consid-
ered of high risk for dehiscence and SSI.13 However, the as-
sociation was maintained even at the multivariate analysis, 
showing this is an independent risk factor in the present 
investigation.
The use of neoadjuvant chemotherapy/radiotherapy for 
rectal neoplasia is associated with better treatment results; 
however, it increases the risk of SSI and other complica-
tions.13,18,24 This is mainly determined by radiotherapy, as the 
surgery is carried out after the conclusion of the adjuvant 
therapy and, obviously, outside the period of neutropenia 
and mucositis that can be induced by chemotherapy. On the 
other hand, radiotherapy causes several local tissue damag-
es, which are very often irreversible, such as vascular lesions 
that lead to ischemia and compromise the venous return and 
lymphatic drainage, decreasing oxygen supply to the irradi-
ated tissues and, consequently, local defenses.13,24 
The present study is also in accordance with the litera-
ture regarding the risk of SSI determined by the duration of 
the surgery.9,12-14,23 Longer interventions increase the risk of 
SSI as they cause higher tissue exposure, as well as surgeries 
that present higher technical complexity or take longer due 
to accidents and complications (hypotension, hemorrhage, 
etc). All these conditions provide better opportunity for mi-
crobial invasion of tissues and the subsequent development 
of infection. 
A good surgical technique is recognized to be one of the 
main SSI prevention measures.1,22 Adequate homeostasis, 
with maintenance of tissue perfusion, careful handling/dis-
section of tissues, devitalized tissue removal and careful use 
of the electrocautery are considered critical points, among 
others. Both the technique and the surgeon’s skills are dif-
ficult to assess.
Generally, the technique/skill is inferred by the surgery 
duration and the incidence of complications such as SSI and 
reoperation, to mention a few. It is known that the learn-
ing curve for the performance of surgical procedures can be 
long and demand a great deal of training, and little is known 
about the necessary time for a surgeon to reach the apex 
for performing a certain type of intervention. Nevertheless, 
most studies do not assess the impact of the the surgeon’s 
years of experience on the incidence of SSI. A study by Wurtz 
et al.25 assessed this variable and found a significant differ-
ence in the SSI incidence between less experienced and more 
experienced surgeons (p < 0.05), after adjusting for possible 
confounders. Muilwijk et al.26 evaluated the risk of SSI based 
on the surgical volume, comparing hospitals and surgeons. 
The surgeries that were part of this study were radical mas-
tectomy, colon resection, appendectomy, total abdominal 
hysterectomy, Cesarean section, partial femoral arthro-
plasty, femoral arthroplasty review and knee arthroplasty. 
No difference was observed in the SSI incidence among the 
different hospitals; however, the surgeons who performed 
the least number of procedures also had the longest time of 
surgery and had a tendency towards higher incidence of SSI. 
Castro, Carvalho, Peres et al.
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The authors concluded that surgeons should be made aware 
of the increased risk of SSI when performing procedures 
that were not frequent in their clinical practice.26 
The ASA score evaluates the basal condition of individu-
als and their comorbidities and, therefore, it is also a good 
predictor for SSI. This association has been demonstrated by 
several authors. However, it has not been observed in the 
town of Barretos, where the incidence of SSI in individuals 
that had ASA > II was 7.7% (2/26), versus 27% (48/178) in 
individuals with ASA ≤ II. When analyzing the association 
between ASA score and time of surgery, it was observed that 
26.4% of the individuals (47/178) with ASA ≤ II, the surgery 
duration was > 235 minutes (75th percentile), whereas the 
same duration occurred in only 11.5% (3/26) of the individ-
uals with ASA > II. It is also noteworthy that 21.5% (38/177) 
of individuals with ASA ≤ II were submitted to palliative 
surgery, whereas 34.6% (9/26) of the individuals with ASA 
III or IV were submitted to this type of surgery. Possibly, 
individuals with more comorbidities had the highest risk of 
surgical complications and thus, were submitted to less ag-
gressive and more conservative surgeries, of shorter dura-
tions. The small sample size, with only 26 participants clas-
sified as ASA > II, might also have influenced the findings of 
the present investigation. 
Some questions were not addressed in the Barretos study. 
Among them, the moment of hair removal, as it is a routine 
procedure in the hospital to perform with an electric shaver 
in the operation room, immediately before degermation and 
aseptic techniques are carried out in the operative field. 
This investigation has several limitations. One is the lack 
of assessment in colon and rectum resections (lower digestive 
system) and whether the colostomy or ileostomy had an impact 
on the incidence of SSI. Similarly, we did not assess the role of 
the persistence of cavity drainage and mainly, the type of drain-
age used. Additionally, it was assessed in the current study the 
quality of intestinal preparation in surgeries that needed such 
preoperative procedure and the occurrence of accidents/com-
plications (hypotension, hypothermia, etc) during the proce-
dure. Although it is a routine at Hospital de Câncer de Barretos 
to perform a preoperative bath, adherence to the procedure and 
its possible interference with the onset of SSI was not studied. 
Other variables, equally not studied, included the impact of SSI 
on the hospitalization time, the need for reoperations and re-
hospitalizations and the increase in healthcare costs. 
CONCLUSION
The following risk factors for SSI were identified in oncolog-
ic surgeries of the digestive system: type of surgery, potential 
for contamination of the surgical wound, time of surgery, 
neoadjuvant radiotherapy applied to the operative field, and 
surgeon’s years of experience. Such factors describe a group 
of individuals at a higher risk for the development of SSI, for 
whom new prevention protocols must be considered. 
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